NCT00582192

Brief Summary

The purpose of this study is to examine doctor-patient communication about treatment options which may include an experimental, new treatment for cancer. What we learn from this study may help us to teach doctors better ways to talk to their patients.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
17

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Jul 2007

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 1, 2007

Completed
6 months until next milestone

First Submitted

Initial submission to the registry

December 21, 2007

Completed
7 days until next milestone

First Posted

Study publicly available on registry

December 28, 2007

Completed
1.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2009

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2009

Completed
Last Updated

May 1, 2009

Status Verified

April 1, 2009

Enrollment Period

1.8 years

First QC Date

December 21, 2007

Last Update Submit

April 30, 2009

Conditions

Cancer

Keywords

Phase I trialOncologists' Communication Styles

Outcome Measures

Primary Outcomes (1)

  • This study aims to use qualitative research methods to examine the pattern of communication strategies oncologists use to discuss Phase I clinical trials ith their patients.

    This study will begin with your appointment with your doctor the day of registration and will end at the end of the visit that day.

Study Arms (1)

1

Participants with certain types of cancers that are eligible for studies at Memorial Sloan-Kettering Cancer Center.

Other: Consult visit

Interventions

Consult visitOTHER

Your appointment with your doctor will be audio taped. The research team will listen to the tape(s) and type them up. The team will then look for patterns in the discussions between patients and doctors. They will use this information to see if the discussions can be improved.

1

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Participants with certain types of cancers that are eligible for studies at Memorial Sloan-Kettering Cancer Center.

You may qualify if:

  • Patients at the outpatient oncology clinics of the six participating physicians (Drs Schwartz, Scher, Slovin, Tse, Shah \& Carvajal)
  • Diagnosed with cancer
  • Eligible for a Phase I trial
  • Discussing participation in such a trial with their physician during their visit

You may not qualify if:

  • Fewer than 18 years of age
  • Not proficient in English
  • Cognitively or physically impaired, rendering them incapable of providing informed consent to participate in the study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Memorial Sloan-Kettering Cancer Center

New York, New York, 10065, United States

Location

Related Links

MeSH Terms

Conditions

Neoplasms

Study Officials

  • Richard Brown, PhD

    Memorial Sloan Kettering Cancer Center

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER

Study Record Dates

First Submitted

December 21, 2007

First Posted

December 28, 2007

Study Start

July 1, 2007

Primary Completion

April 1, 2009

Study Completion

April 1, 2009

Last Updated

May 1, 2009

Record last verified: 2009-04

Locations

US(1)